Hedge Fund and Insider Trading News: George Soros, Jim Simons, Three Arrows Capital, Rocket Companies Inc (RKT), Titan Pharmaceuticals, Inc. (TTNP), and More

Page 2 of 2

Abrdn Launches First Hedge-Fund Index Trackers (The Wall Street Journal)
Abrdn PLC (ABDN) is bringing index investing to the $5 trillion hedge-fund universe. The asset manager is launching a platform called Eclipse, which it says will be the first to give institutional investors passive exposure to hedge-fund strategies through indexes built by Hedge Fund Research Inc.

Hedge Funds Fall 5.9% in First Half (The Express Tribune)
NEW YORK: Hedge funds posted a negative performance in June, bringing losses this year to almost 6%, as volatility across markets accelerated, a report by hedge fund data provider HFR showed on Friday. The fund weighted composite index fell 3.08% last month. All main four different hedge fund categories tracked by HFR – equity, event-driven, macro and relative value – posted losses in June.

Hedge Fund Backed by KKR Bets India Stocks to Rise, CPI to Fall (Bloomberg)
Indian stocks are an attractive bet because inflation has peaked and this will become evident in price data within a few months, according to a hedge fund backed by KKR & Co. “We are big on consumer discretionary, led by auto, and industrials — these industries will immensely benefit when prices fall,” Vaibhav Sanghavi, co-Chief Executive Officer of Avendus Capital Public Markets Alternate Strategies, said in an interview in Mumbai.

Monday 7/11 Insider Buying Report: RKT, ESTE (Nasdaq.com)
On Wednesday, Rocket Companies’ Chief Executive Officer, Jay Farner, made a $398,214 buy of RKT, purchasing 48,600 shares at a cost of $8.19 a piece. Farner was up about 7.2% on the purchase at the high point of today’s trading session, with RKT trading as high as $8.79 at last check today. Rocket Companies is trading up about 0.2% on the day Monday. Before this latest buy, Farner bought RKT at 29 other times during the past year, for a total investment of $13.04M at an average of $8.52 per share. And also on Wednesday, Director Jay Frederick Joliat purchased $235,963 worth of Earthstone Energy, purchasing 20,237 shares at a cost of $11.66 each. This purchase marks the first one filed by Joliat in the past year. Earthstone Energy is trading trading flat on the day Monday. Joliat was up about 5.9% on the buy at the high point of today’s trading session, with ESTE trading as high as $12.35 at last check today.

Insider Trading: July 11, 2022 (BIV.com)
Insider James A Pattison, 10 per cent owner. Company: Westshore Terminals Investment Corp. (TSX:WTE). Shares owned: 4,719,541. Trade date: Jun 24. Trade total: $5,049,600. Trade: Acquisition of 160,000 shares at a price of $31.56 per share. Insider Stuart Raftus, officer. Company: Canaccord Genuity Group Inc. (TSX:CF). Shares owned: 2,010,586. Trade date: Jun 23. Trade total: $1,740,000. Trade: Acquisition of 200,000 shares at a price of $8.70 per share.

Around $2 Million Bet On This Stock? 4 Penny Stocks Insiders are Buying (Benzinga)
Titan Pharmaceuticals: The Trade: Titan Pharmaceuticals, Inc. (TTNP) 10% owner Activist Investing LLC acquired a total of 2,226,190 shares at an average price of $0.86. To acquire these shares, it cost around $1.92 million. SeaChange International: The Trade: SeaChange International, Inc. (SEAC) 10% owner Karen Singer acquired a total of 201,978 shares at an average price of $0.57. The insider spent around $115.1 thousand to buy those shares.

Former Business Development Executive and Two Friends Charged with Insider Trading (HedgeCo.net)
(HedgeCo.Net) The Securities and Exchange Commission has filed insider trading charges yesterday against Doron A. Tavlin, the former Vice President, Business Development of Mazor Robotics Ltd., and two friends who made more than $500,000 in profits from trading in advance of Mazor’s announcement that it would be acquired by Medtronic plc. According to the SEC’s complaint, filed in federal court in Minnesota, Tavlin tipped his friend Afshin Farahan regarding Mazor’s impending acquisition by Medtronic. The complaint alleges that Farahan used the information to buy Mazor stock and also tipped his friend, David J. Gantman, who purchased Mazor stock and call options in advance of the September 20, 2018 acquisition announcement.

Page 2 of 2